Based on the pathway enrichment analysis, targets (INSR, PTPN1, PPARA, PPARG) from two of the most significant pathways, Insulin resistance, and PPAR signaling pathway, were selected for further experimental validation. The gene discussed is PPARA; the disease is Insulin resistance.